implementation of appropriate risk management and resource allocation by their board of directors and executives that is practical and meets the standards established by an international organization concerning

income 47.97 100.00 79.46 100.00 (39.63) Costs 18.79 39.17 42.14 53.03 (55.41) Administrative expenses, finance costs and share of loss from associates 37.52 78.22 29.56 37.20 26.93 Management benefit

วันที่ 15 ตุลาคม 2545 1 NO. (SUTHA-SET) 008/2020/EN 14 May 2020 Subject: Management Discussion and Analysis of the Company and its subsidiary for period ended 31 March 2020 To: The President of the

with the Company : Buyer has no relationship with the Company or (1) directors and management (2) persons with controlling power (3) major shareholders of the Company; or (4) other companies having the

23 April 2018 At: ACC/HO 016/61 Re: Management Discussion and Analysis for the three-month period ended 31 March 2018 To: President The Stock Exchange of Thailand During the first quarter of 2018 the

income and other income 53.24 100.00 188.89 100.00 Costs 20.59 38.67 114.29 60.51 Administrative expenses, impairment finance costs and share of loss from associates 108.96 204.66 50.22 26.58 Management

million from the same period of the prior year. Construction revenue decreased because Xayaburi Hydroelectric Power Project is now close to project completion. Also, in Q2 2017, the Company accelerated

, 2019 Subject Explanation and analysis of Management for second quarter 2019 Attention Directors and manager The Stock Exchange of Thailand Inter pharma Public Company Limited (“the Company”) would like

PowerPoint Presentation After You Public Company Limited Management Discussion & Analysis Q3/2020 Management Discussion & Analysis Q3/2020 Gross Profit and Gross Profit Margin • The Company’s gross

) กิจการ https://publish.sec.or.th/nrs/7972s.pdf E_1 Legal_FA_2015_12_29-c E_1 Legal_FA_2015_12_29-c A CorpL4.1hig A Executive Summary of Management Discussion and Analysis 1 For the Year Ending December 31